Something's New Since You Were Last With Us

Balance is now part of the ImPACT platform. Objective balance data, built into the tools you already know.

Landing Page

What's New

Balance impairment is a common component of concussion and may persist even after symptoms improve. Objective balance assessment provides athletic trainers with additional information to evaluate athletes, monitor recovery, and make more informed return-to-learn and return-to-play decisions. 

Balance complements cognitive and symptom assessments, helping providers build a more complete picture of patient recovery. 

Why Balance Matters

Balance impairment is a common component of concussion and may persist even after symptoms improve. Objective balance assessment gives athletic trainers additional data to inform return-to-learn and return-to-play decisions, complementing existing cognitive and symptom assessments. 

Built for the Sideline

If ease of use or sideline flexibility played a role in your program looking elsewhere, that's changed. 
 
Balance runs on mobile and works independently of cognitive testing, so you're not locked into a full lab setup every time. Athletes can complete an assessment in minutes, wherever your team is. 

ImPACT Balance Right

Worth Another Look?

If ease of use or sideline flexibility played a role in your program looking elsewhere, that's changed.

Balance runs on mobile and works independently of cognitive testing, so you're not locked into a full lab setup every time. Athletes can complete an assessment in minutes, wherever your team is. 

We built this because programs told us speed and portability mattered as much as the data itself. Worth a second look if that was ever the sticking point. 

ImPACT Applications Inc

ImPACT Applications, Inc., a Riverside Insights® company, is the maker of ImPACT, ImPACT Pediatric, and ImPACT Quick Test, all FDA cleared medical devices(opens in new tab) that assist in the assessment and management of concussion. See our milestones(opens in new tab) here and access our press releases(opens in new tab) here.